As a #biotech #CEO, you lead with audacious #vision, chasing #cures and pushing the boundaries of #science. But the path to market is fraught with uncertainty - soaring development #costs, blind spots in early #efficacy, and the chilling #risk of clinical trial failures, while securing #funding can feel like a moonshot. IAG, IMAGE ANALYSIS GROUP is your #imaging expert partner in planning and executing clinical trials, and commercializing clinical stage assets. By bringing years of expertise in radiology, strategic thinking and smart investments, we support drug development efforts through clinical trials to market entry. Our biotech portfolio companies take advantage of a range of innovative R&D #solutions, risk-sharing #financing and partnership models, early visibility of study performance through #DYNAMIKA platform and tailored strategy for potential pharmaceutical #partnerships. IAG will attend #JPM24 in San Francisco, USA, 8-11 January 2024. Schedule a meeting: bio-partnering@ia-grp.com, with Dr. Olga Kubassova, Julia O'Lynn, R.T. (R)(M)(MR), David Cattaneo, Michael Clark, Roughan Sheedy #biotechceo #drugdevelopment #clinicaltrials #lifescience #innovation #pharmaceutical #healthcare #aihealthcare #digitalhealth #medtech #venturecapital #investments #marketleader #disruptivetechnology #earlystage #entrepreneur #biotechweek #efficacychallenges #patientrecruitment #clinicaltrialdropout #fundinggap #marketuncertainty #riskmanagement #drugdiscovery #personalizedmedicine #futureofhealthcare #breakthroughtherapy #lifesavingtreatment #unmetmedicalneeds #gotomarketstrategy #biotechpartner #lifesciencesuccess #drugcommercialization #nextgenmedicine
IAG making waves at JPM, as always!!